Corvent Medical
Fargo, US · Founded 2020 · Delaware corporation · 42 employees on LinkedIn · 1 known investors
Find your way into Corvent Medical
222 people in our graph share verified history with the Corvent Medical team — schools, employers, funds. One of them is your warm intro.
Bill Millerunlockedknows Murphy Travis · together at University of Illinois Urbana-Champaign (overlapped)
×2knows the team · via Embry-Riddle Aeronautical University
knows the team · via University of Illinois Urbana-Champaign
×8knows the team · via UMN Carlson School of Management
CorVent Medical develops medical ventilators, including the RESPOND ventilator, that provide ICU-standard respiratory support for acute and post-acute patients. Its systems are designed for hospitals, clinics, and private care providers for both daily use and overflow or emergency situations.
Founders & leadership
MT
Murphy TravisinChief Financial OfficerExecutive Officer at CorVent Medical, which develops medical ventilators for ICU-level respiratory support. Travis brings over three decades of financial leadership experience across startups and growing healthcare technology companies, including work in finance, accounting, strategic planning, and fundraising from private equity, public markets, and debt sources.
JN
Jeremy NelsoninExecutive
RS
Richard S. WalshinCEO, CorVent MedicalRichard S. Walsh is CEO and Board Member at CorVent Medical. With over 30 years in medical device leadership, he has held cross-functional roles in sales, marketing, regulatory affairs, and investor relations at multiple companies, and previously participated in liquidity events involving billions in enterprise value.
JO
John O'MahonyinChief Technology Officer
RF
Rob FaulknerNamed on SEC filing
LG
Lukas GeuntherNamed on SEC filing
Board
MG
MT
Mark TibblesBoard director
JO
John O'ConnorBoard director
RS
Randy SchneiderBoard director
JB
John BallantyneBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$13.7M disclosed across 3 rounds · 2020–2024
▶$3.8MraisedJun 2025 · 4 investors · Other Health CareRule 506(b)
▶$3.8MraisedJun 2025 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard S. WalshExecutive Officer, Director
- Jeremy NelsonExecutive Officer
- John O'ConnorDirector
- Mark GelfandDirector
- John A. BallantyneDirector
- Travis MurphyExecutive Officer
- John O'MahonyExecutive Officer
- Randy SchneiderDirector
- Offering amount
- $6.5M
- Amount sold
- $3.8M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$5.4MraisedDec 2024 · 6 investors · Other Health CareRule 506(b)
▶$5.4MraisedDec 2024 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Murphy TravisExecutive Officer
- Jeremy NelsonExecutive Officer
- Mark GelfandDirector
- Mark TibblesDirector
- Richard S. WalshExecutive Officer, Director
- John O'ConnorDirector
- John O'MahonyExecutive Officer
- Randy SchneiderDirector
- John BallantyneDirector
- Offering amount
- $5.4M
- Amount sold
- $5.4M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$4.5MraisedMay 2020 · 6 investors · Other Health CareRule 506(b)
▶$4.5MraisedMay 2020 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark GelfandExecutive Officer, Director
- Rob FaulknerDirector
- Lukas GeuntherDirector
- Offering amount
- $4.5M
- Amount sold
- $4.5M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Rf Surgical10 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Arrivent6 shared keywordsArriVent BioPharma is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing medicines for difficult-to-treat diseases, starting with cancers. Its pipeline centers on its lead candidate firmonertinib (formerly furmonertinib) and novel oncology therapeutics such as next-generation antibody drug conjugates.
Solventum6 shared keywordsSolventum is a healthcare company that develops medical solutions, including wound care technology such as Acera Surgical's Restrata product, for surgeons, patients, and the broader healthcare sector.
Companies competing with Corvent Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Corvent Medical do?
- CorVent Medical develops medical ventilators, including the RESPOND ventilator, that provide ICU-standard respiratory support for acute and post-acute patients. Its systems are designed for hospitals, clinics, and private care providers for both daily use and overflow or emergency situations.
- Who are Corvent Medical's investors?
- Corvent Medical's investors include Sofinnova Partners.
- How much funding has Corvent Medical raised?
- Corvent Medical has disclosed $13.7M raised across 3 rounds.
- Where is Corvent Medical headquartered?
- Corvent Medical is headquartered in Fargo, US.